# FDA recall D-0051-2025

> **Tailstorm Health INC** · Class II · drug recall initiated 2024-11-06.

## Product

BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1

## Reason for recall

Lack of Sterility Assurance

## Distribution

Nationwide Within U.S.

## Key facts

- **Recall number:** D-0051-2025
- **Recalling firm:** Tailstorm Health INC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-11-06
- **Report date:** 2024-11-27
- **Termination date:** 2025-03-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Phoenix, AZ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0051-2025

## Citation

> AI Analytics. FDA recall D-0051-2025. Retrieved 2026-07-25 from https://api.ai-analytics.org/recall/D-0051-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*